Literature DB >> 11932345

Acromegaly and colorectal cancer: risk assessment should be based on population-based studies.

Andrew G Renehan, Stephen M Shalet.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11932345     DOI： 10.1210/jcem.87.4.8369

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

1.  Guidelines for colonoscopic screening in acromegaly are inconsistent with those for other high risk groups.

Authors:  A G Renehan; S T O'Dwyer; S M Shalet
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

Review 2.  Acromegaly and Colorectal Neoplasm: An Update.

Authors:  Leandro Kasuki; Bernardo Maia; Mônica R Gadelha
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-20       Impact factor: 6.055

Review 3.  Current diagnosis of acromegaly.

Authors:  Rocio A Cordero; Ariel L Barkan
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

4.  GH-secreting pituitary macroadenoma (acromegaly) associated with progressive dental malocclusion and refractory CPAP treatment.

Authors:  Jaume Miranda-Rius; Lluís Brunet-LLobet; Eduard Lahor-Soler; David de Dios-Miranda; Josep Anton Giménez-Rubio
Journal:  Head Face Med       Date:  2017-05-10       Impact factor: 2.151

5.  Therapeutic options in the management of acromegaly: focus on lanreotide Autogel.

Authors:  Ferdinand Roelfsema; Nienke R Biermasz; Alberto M Pereira; Johannes A Romijn
Journal:  Biologics       Date:  2008-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.